Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pressure tuning of the optical properties of GaAs nanowires.
Zardo I, Yazji S, Marini C, Uccelli E, Fontcuberta i Morral A, Abstreiter G, Postorino P. Zardo I, et al. Among authors: yazji s. ACS Nano. 2012 Apr 24;6(4):3284-91. doi: 10.1021/nn300228u. Epub 2012 Mar 29. ACS Nano. 2012. PMID: 22443867
Local modification of GaAs nanowires induced by laser heating.
Yazji S, Zardo I, Soini M, Postorino P, Fontcuberta i Morral A, Abstreiter G. Yazji S, et al. Nanotechnology. 2011 Aug 12;22(32):325701. doi: 10.1088/0957-4484/22/32/325701. Epub 2011 Jul 14. Nanotechnology. 2011. PMID: 21757796 Free article.
Pressure dependence of Raman spectrum in InAs nanowires.
Yazji S, Zardo I, Hertenberger S, Morkötter S, Koblmüller G, Abstreiter G, Postorino P. Yazji S, et al. J Phys Condens Matter. 2014 Jun 11;26(23):235301. doi: 10.1088/0953-8984/26/23/235301. J Phys Condens Matter. 2014. PMID: 25932470
A first-in-human phase I study to evaluate the MEK1/2 inhibitor, cobimetinib, administered daily in patients with advanced solid tumors.
Rosen LS, LoRusso P, Ma WW, Goldman JW, Weise A, Colevas AD, Adjei A, Yazji S, Shen A, Johnston S, Hsieh HJ, Chan IT, Sikic BI. Rosen LS, et al. Among authors: yazji s. Invest New Drugs. 2016 Oct;34(5):604-13. doi: 10.1007/s10637-016-0374-3. Epub 2016 Jul 16. Invest New Drugs. 2016. PMID: 27424159 Free PMC article. Clinical Trial.
Phase III study of nilotinib versus best supportive care with or without a TKI in patients with gastrointestinal stromal tumors resistant to or intolerant of imatinib and sunitinib.
Reichardt P, Blay JY, Gelderblom H, Schlemmer M, Demetri GD, Bui-Nguyen B, McArthur GA, Yazji S, Hsu Y, Galetic I, Rutkowski P. Reichardt P, et al. Among authors: yazji s. Ann Oncol. 2012 Jul;23(7):1680-7. doi: 10.1093/annonc/mdr598. Epub 2012 Feb 21. Ann Oncol. 2012. PMID: 22357255 Free article. Clinical Trial.
15 results